Point72 Asset Management L.P. Has $50.55 Million Position in ICU Medical, Incorporated (ICUI)

Point72 Asset Management L.P. raised its stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 65.0% in the 1st quarter, Holdings Channel reports. The firm owned 200,256 shares of the medical instruments supplier’s stock after purchasing an additional 78,856 shares during the quarter. Point72 Asset Management L.P.’s holdings in ICU Medical were worth $50,545,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of ICUI. Schwab Charles Investment Management Inc. raised its position in shares of ICU Medical by 6.5% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 71,751 shares of the medical instruments supplier’s stock worth $15,499,000 after acquiring an additional 4,360 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of ICU Medical by 39.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 984 shares of the medical instruments supplier’s stock worth $213,000 after acquiring an additional 277 shares in the last quarter. Aperio Group LLC raised its position in shares of ICU Medical by 4.2% in the 4th quarter. Aperio Group LLC now owns 8,102 shares of the medical instruments supplier’s stock worth $1,750,000 after acquiring an additional 326 shares in the last quarter. Teacher Retirement System of Texas raised its position in shares of ICU Medical by 323.3% in the 4th quarter. Teacher Retirement System of Texas now owns 5,503 shares of the medical instruments supplier’s stock worth $1,189,000 after acquiring an additional 4,203 shares in the last quarter. Finally, Daiwa Securities Group Inc. bought a new position in shares of ICU Medical in the 4th quarter worth about $3,553,000. 72.23% of the stock is owned by hedge funds and other institutional investors.

In related news, Director George A. Lopez sold 13,443 shares of the business’s stock in a transaction dated Monday, March 19th. The stock was sold at an average price of $249.66, for a total value of $3,356,179.38. Following the completion of the sale, the director now directly owns 526,574 shares of the company’s stock, valued at approximately $131,464,464.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director George A. Lopez sold 12,600 shares of the business’s stock in a transaction dated Monday, June 4th. The shares were sold at an average price of $293.17, for a total value of $3,693,942.00. Following the completion of the sale, the director now directly owns 426,016 shares of the company’s stock, valued at $124,895,110.72. The disclosure for this sale can be found here. Insiders sold a total of 148,886 shares of company stock valued at $39,614,760 over the last ninety days. 12.50% of the stock is currently owned by corporate insiders.

Several research analysts have recently weighed in on ICUI shares. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. TheStreet lowered ICU Medical from an “a” rating to a “c+” rating in a research report on Wednesday, May 9th. Zacks Investment Research lowered ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 3rd. Finally, ValuEngine raised ICU Medical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 2nd. One equities research analyst has rated the stock with a hold rating, one has issued a buy rating and three have assigned a strong buy rating to the company’s stock. ICU Medical currently has a consensus rating of “Buy” and a consensus price target of $311.00.

Shares of ICU Medical opened at $304.10 on Thursday, MarketBeat Ratings reports. ICU Medical, Incorporated has a one year low of $164.00 and a one year high of $307.30. The stock has a market capitalization of $5.90 billion, a P/E ratio of 55.09 and a beta of 0.36.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Wednesday, May 9th. The medical instruments supplier reported $2.26 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.42. ICU Medical had a return on equity of 9.55% and a net margin of 1.25%. The business had revenue of $372.00 million during the quarter, compared to analyst estimates of $346.28 million. During the same period in the previous year, the company posted $1.68 EPS. The firm’s revenue was up 50.2% compared to the same quarter last year. equities analysts anticipate that ICU Medical, Incorporated will post 6.66 earnings per share for the current fiscal year.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit